ASCO 2025: Where Oncology’s Brightest Minds Meet—and Clinakos Inc. Listens Closely
We’re back from the American Society of Clinical Oncology (ASCO) Annual Meeting, energized and inspired by the innovations shaping the future of cancer care. It was especially good seeing our partner Wes Michael of Rare Patient Voice—collaborations like these are vital as we work together to elevate the patient perspective in oncology.

Here are the specific takeaways that will guide our work at Clinakos:

🔍Real-World Data is Revolutionizing Clinical Trials
ASCO spotlighted how real-world data (RWD) is now being used to complement—and sometimes even replace—traditional control arms in clinical trials. The session on “Synthetic Control Arms: The New Gold Standard?” showed that leveraging large, diverse patient datasets can accelerate trial timelines and improve representativeness. Clinakos’ Integrated Patient Data™ platform is already enabling sponsors to build more robust, inclusive studies.

🤖 AI in Oncology: From Hype to Hands-On Impact
The panel “AI in Tumor Board Decision-Making” demonstrated how AI-driven tools are being integrated into multidisciplinary teams to support personalized treatment plans. Clinakos’ Medically Smart AI™ is designed to surface actionable insights from complex data, helping clinicians make confident, evidence-based decisions—faster.

🧬 Biomarker-Driven Therapies Are Expanding
Sessions on next-generation sequencing and liquid biopsies proved that the future of oncology is deeply personalized. The discussion on “Beyond PD-L1: New Biomarkers in Immuno-Oncology” highlighted the need for platforms that can aggregate and interpret multi-modal biomarker data. Clinakos is committed to making this seamless for researchers and clinicians alike.

📝 Patient-Reported Outcomes (PROs) Are Essential
The focus on PROs, especially in the session “Integrating the Patient Voice in Oncology Trials,” underscored that understanding quality of life and symptom burden is as important as clinical endpoints. Our platform is evolving to better capture and integrate PROs, ensuring patients’ voices are heard at every step.

🌍 Equity and Access Remain Top Priorities
ASCO’s emphasis on “Closing the Care Gap” reminded us that technology must be an equalizer, not a divider. Clinakos is dedicated to building solutions that democratize access to cutting-edge care and data-driven insights for all patient populations.

We’re excited to turn these learnings into real-world impact. If you’re passionate about advancing oncology through smarter data and technology, let’s connect!

📲 Stay connected—follow Clinakos Inc. for the latest news and updates.